BUSINESS & FINANCE
Mitomycin C Market Research: Global Industry Analysis and Forecast
In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Mitomycin C market for 2018-2023.
Mitomycin C market, Mitomycin C is an antibiotic which acts as a double-stranded DNA alkylating agent. It covalently crosslinks DNA, inhibiting DNA synthesis and cell proliferation It acts by way of reductive activation either through low pH or NAD(P)H:quinone oxidoreductase (DT-diaphorase) or NADH cytochrome c reductase (Mao et al.; Cummings et al.).
In the last several years, Global market of Mitomycin C was experienced an upward trend rapidly, with an average growth rate of 4.76%. In 2016, Global Revenue of Mitomycin C is nearly 119.83 M USD; the actual production is about 17370 K Unit.
Also Reda About:
https://jennifermitchell.tribe.so/post/news-with-print-and-electronic-media-62d8346a465b8b2210b7ddaf
The global average price of Mitomycin C is in the increasing trend, from 6.30 USD/Unit in 2012 to 6.90 USD/Unit in 2016. With the situation of global economy, prices will be in increasing trend in the following five years.
The classification of Mitomycin C includes 2 Mg, 10 Mg, 40 Mg, and others. The proportion of 2 Mg in 2016 is about 41.5%, and the proportion is in decreasing trend from 2012 to 2016.
Mitomycin C is widely used in Cancer Treatment, Ophthalmic Use, and other field. The most proportion of Mitomycin C is Cancer Treatment, and the proportion in 2016 is 69%. The trend of Cancer Treatment is decreasing.
Japan is the largest supplier of Mitomycin C, with a production market share nearly 26.5% in 2016. India is the second largest supplier of Mitomycin C Media, enjoying production market share nearly 25% in 2016.
North America is the largest consumption place, with a consumption market share nearly 36% in 2016. Following North America, Europe is the second largest consumption place with the consumption market share of 32.6%.
Over the next five years, LPI(LP Information) projects that Mitomycin C will register a -2.3% CAGR in terms of revenue, reach US$ 100 million by 2023, from US$ 120 million in 2017.
Also Read About:
https://www.snipesocial.co.uk/blogs/100819/All-Your-Business-News-With-Print-And-Electronic-Media
https://www.snipesocial.co.uk/blogs/100820/The-Best-Business-News-Now-a-Click-Away
https://www.snipesocial.co.uk/blogs/100821/Mobile-Development-Trends
https://www.snipesocial.co.uk/blogs/100822/How-Business-News-Facilitates-the-Right-Investment
https://www.snipesocial.co.uk/blogs/100823/Read-Business-News-Daily-To-Keep-Up-With-the-Markets
This report presents a comprehensive overview, market shares, and growth opportunities of Mitomycin C market by product type, application, key manufacturers and key regions.
